{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:26Z","timestamp":1786985186688,"version":"build-2736575974"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009793","name":"Chapman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["HL147311-S1"],"award-info":[{"award-number":["HL147311-S1"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biomaterials.2023.122329","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T05:29:10Z","timestamp":1694582950000},"page":"122329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Folate conjugated nanomedicines for selective inhibition of mTOR signaling in polycystic kidneys at clinically relevant doses"],"prefix":"10.1016","volume":"302","author":[{"given":"Rajasekharreddy","family":"Pala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-1183","authenticated-orcid":false,"given":"Ayan K.","family":"Barui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf M.","family":"Mohieldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-0287","authenticated-orcid":false,"given":"Surya M.","family":"Nauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5266","key":"10.1016\/j.biomaterials.2023.122329_bib1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib2","first-page":"289","article-title":"The complete structure of the PKD1 gene and its protein","volume":"81","year":"1995","journal-title":"The International Polycystic Kidney Disease Consortium, Cell"},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122329_bib3","doi-asserted-by":"crossref","first-page":"F1034","DOI":"10.1152\/ajprenal.00195.2003","article-title":"Murine models of polycystic kidney disease: molecular and therapeutic insights","volume":"285","author":"Guay-Woodford","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122329_bib4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1681\/ASN.2020070991","article-title":"Mtor haploinsufficiency ameliorates renal cysts and cilia abnormality in adult zebrafish tmem67 mutants","volume":"32","author":"Zhu","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biomaterials.2023.122329_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109730","article-title":"Increased mTOR and suppressed autophagic flux in the heart of a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease","volume":"74","author":"Atwood","year":"2020","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122329_bib6","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1111\/jcmm.14506","article-title":"Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines","volume":"23","author":"Papavassiliou","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122329_bib7","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1080\/15548627.2020.1782035","article-title":"PKD2\/polycystin-2 induces autophagy by forming a complex with BECN1","volume":"17","author":"Pena-Oyarzun","year":"2021","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122329_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.cdd.4401815","article-title":"Loss of PKD1 and loss of Bcl-2 elicit polycystic kidney disease through distinct mechanisms","volume":"13","author":"Hughes","year":"2006","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122329_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1046\/j.1523-1755.2002.00250.x","article-title":"Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease","volume":"61","author":"Ecder","year":"2002","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122329_bib10","first-page":"2210","article-title":"c-myc-induced apoptosis in polycystic kidney disease is independent of FasL\/Fas interaction","volume":"62","author":"Couillard","year":"2002","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122329_bib11","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1084\/jem.186.11.1873","article-title":"C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent","volume":"186","author":"Trudel","year":"1997","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122329_bib12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00109-012-0902-3","article-title":"Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation","volume":"90","author":"Aguiari","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"39","key":"10.1016\/j.biomaterials.2023.122329_bib13","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122329_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2013.102","article-title":"Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury","volume":"84","author":"Zhou","year":"2013","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122329_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ki.2012.435","article-title":"Role of epidermal growth factor receptor in acute and chronic kidney injury","volume":"83","author":"Tang","year":"2013","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122329_bib16","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1159\/000109828","article-title":"Attenuation of glycerol-induced acute kidney injury by previous partial hepatectomy: role of hepatocyte growth factor\/c-met axis in tubular protection","volume":"107","author":"Homsi","year":"2007","journal-title":"Nephron Exp. Nephrol."},{"issue":"12","key":"10.1016\/j.biomaterials.2023.122329_bib17","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1097\/01.ASN.0000098681.56240.1A","article-title":"Importance of functional EGF receptors in recovery from acute nephrotoxic injury","volume":"14","author":"Wang","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122329_bib18","first-page":"724","article-title":"Insulin-like growth factor-1 enhances epidermal growth factor receptor activation and renal tubular cell regeneration in postischemic acute renal failure","volume":"125","author":"Lin","year":"1995","journal-title":"J. Lab. Clin. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.18632\/oncotarget.440","article-title":"c-MYC and SIRT1 locked in a vicious cycle","volume":"3","author":"Menssen","year":"2012","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib20","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.23650","article-title":"Regulation of STATs by polycystin-1 and their role in polycystic kidney disease","volume":"2","author":"Weimbs","year":"2013","journal-title":"JAK-STAT"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","article-title":"PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2","volume":"109","author":"Bhunia","year":"2002","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122329_bib22","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122329_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122329_bib24","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2011030277","article-title":"c-Met and NF-kappaB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease","volume":"23","author":"Qin","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122329_bib25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCULATIONAHA.113.005746","article-title":"Survivin-induced abnormal ploidy contributes to cystic kidney and aneurysm formation","volume":"129","author":"Aboualaiwi","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122329_bib26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1083\/jcb.201012061","article-title":"Aurora A kinase activity influences calcium signaling in kidney cells","volume":"193","author":"Plotnikova","year":"2011","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122329_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis ameliorates renal cyst growth in polycystic kidney disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122329_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1523-1755.2001.00465.x","article-title":"Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats","volume":"59","author":"Aukema","year":"2001","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122329_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.akdh.2023.01.003","article-title":"Autosomal dominant polycystic kidney disease therapies on the horizon","volume":"30","author":"Zhou","year":"2023","journal-title":"Adv Kidney Dis Health"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","author":"Wilson","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000314380","article-title":"The mTOR pathway is activated in human autosomal-recessive polycystic kidney disease","volume":"33","author":"Becker","year":"2010","journal-title":"Kidney Blood Press. Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122329_bib32","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/ndt\/gfn744","article-title":"Activation of the AKT\/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD)","volume":"24","author":"Fischer","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"14","key":"10.1016\/j.biomaterials.2023.122329_bib33","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122329_bib34","doi-asserted-by":"crossref","first-page":"F236","DOI":"10.1152\/ajprenal.00129.2010","article-title":"mTORC1\/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease","volume":"300","author":"Belibi","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122329_bib35","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease","volume":"78","author":"Zafar","year":"2010","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122329_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122329_bib37","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfp129","article-title":"Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)","volume":"24","author":"Zafar","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122329_bib38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122329_bib39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","article-title":"Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease","volume":"23","author":"Novalic","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122329_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ndt\/gfq384","article-title":"Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats","volume":"26","author":"Renken","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122329_bib41","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122329_bib42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122329_bib43","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122329_bib44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.krcp.2012.07.002","article-title":"Mammalian target of rapamycin inhibition in polycystic kidney disease: from bench to bedside","volume":"31","author":"Kim","year":"2012","journal-title":"Kidney Res Clin Pract"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/med.21532","article-title":"Targeting strategies for drug delivery to the kidney: from renal glomeruli to tubules","volume":"39","author":"Liu","year":"2019","journal-title":"Med. Res. Rev."},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122329_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41551-018-0317-8","article-title":"DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury","volume":"2","author":"Jiang","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122329_bib47","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/nl504610d","article-title":"Mesoscale nanoparticles selectively target the renal proximal tubule epithelium","volume":"15","author":"Williams","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2023.122329_bib48","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jconrel.2020.10.047","article-title":"Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease","volume":"329","author":"Wang","year":"2021","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122329_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801358","article-title":"Safe nanocomposite-mediated efficient delivery of MicroRNA plasmids for autosomal dominant polycystic kidney disease (ADPKD) therapy","volume":"8","author":"Tsai","year":"2019","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2023.122329_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.11.019","article-title":"Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys","volume":"293","author":"Shi","year":"2019","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122329_bib51","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1681\/ASN.2012040367","article-title":"Folate-conjugated rapamycin slows progression of polycystic kidney disease","volume":"23","author":"Shillingford","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib52","doi-asserted-by":"crossref","first-page":"F395","DOI":"10.1152\/ajprenal.00057.2018","article-title":"Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease","volume":"315","author":"Kipp","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6380","key":"10.1016\/j.biomaterials.2023.122329_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao5902","article-title":"Chemically induced proximity in biology and medicine","volume":"359","author":"Stanton","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2023.122329_bib54","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.immunol.16.1.569","article-title":"Dimerization as a regulatory mechanism in signal transduction","volume":"16","author":"Klemm","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2023.122329_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5828120","article-title":"Mito-TEMPO alleviates renal fibrosis by reducing inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress","volume":"2018","author":"Liu","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122329_bib56","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1681\/ASN.2011070711","article-title":"Folate receptor-targeted antioxidant therapy ameliorates renal ischemia-reperfusion injury","volume":"23","author":"Knight","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"14","key":"10.1016\/j.biomaterials.2023.122329_bib57","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/hmg\/ddp190","article-title":"Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways","volume":"18","author":"Happe","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"14","key":"10.1016\/j.biomaterials.2023.122329_bib58","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/hmg\/ddp147","article-title":"Renal injury is a third hit promoting rapid development of adult polycystic kidney disease","volume":"18","author":"Takakura","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biomaterials.2023.122329_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.134970","article-title":"Synthesis, bioactive properties, and biomedical applications of intrinsically therapeutic nanoparticles for disease treatment","volume":"435","author":"Nguyen","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biomaterials.2023.122329_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119961","article-title":"Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: a push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy","volume":"243","author":"Luo","year":"2020","journal-title":"Biomaterials"},{"issue":"Pt B","key":"10.1016\/j.biomaterials.2023.122329_bib61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2023.122329_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-016-0183-z","article-title":"Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations","volume":"14","author":"Fasehee","year":"2016","journal-title":"J. Nanobiotechnol."},{"issue":"13","key":"10.1016\/j.biomaterials.2023.122329_bib63","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/j.bmc.2011.05.016","article-title":"Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma","volume":"19","author":"Liang","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biomaterials.2023.122329_bib64","series-title":"In Vitro Delivery of mTOR Inhibitors by Kidney-Targeted Micelles for Autosomal Dominant Polycystic Kidney Disease","author":"Cox","year":"2023"},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122329_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9250","article-title":"Erythrocyte leveraged chemotherapy (ELeCt): nanoparticle assembly on erythrocyte surface to combat lung metastasis","volume":"5","author":"Zhao","year":"2019","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib66","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/acs.nanolett.8b04138","article-title":"Personalized nanotherapy by specifically targeting cell organelles to improve vascular hypertension","volume":"19","author":"Pala","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2023.122329_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114056","article-title":"Rapamycin treatment correlates changes in primary cilia expression with cell cycle regulation in epithelial cells","volume":"178","author":"Jamal","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1076","article-title":"Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells","volume":"33","author":"Nauli","year":"2003","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122329_bib69","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCULATIONAHA.107.710111","article-title":"Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1","volume":"117","author":"Nauli","year":"2008","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.biomaterials.2023.122329_bib70","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41565-020-00820-0","article-title":"Nanomedicine and the COVID-19 vaccines","volume":"15","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2023.122329_bib71","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.2147\/IJN.S136488","article-title":"Dual tumor-targeted poly(lactic-co-glycolic acid)-polyethylene glycol-folic acid nanoparticles: a novel biodegradable nanocarrier for secure and efficient antitumor drug delivery","volume":"12","author":"Chen","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122329_bib72","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/nnm.12.31","article-title":"Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomedicine (Lond)"},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122329_bib73","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0024-3205(97)00539-0","article-title":"Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles","volume":"61","author":"Peracchia","year":"1997","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib74","article-title":"Capillary endothelia from two ADPKD patients are polyploidy","volume":"2","author":"Kathem","year":"2016","journal-title":"Ann Clin Cytol Pathol"},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122329_bib75","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/hmg\/ddt556","article-title":"SIRT2 regulates ciliogenesis and contributes to abnormal centrosome amplification caused by loss of polycystin-1","volume":"23","author":"Zhou","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib76","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/hmg\/ddq470","article-title":"Endothelial cells from humans and mice with polycystic kidney disease are characterized by polyploidy and chromosome segregation defects through survivin down-regulation","volume":"20","author":"AbouAlaiwi","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122329_bib77","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCRESAHA.108.192765","article-title":"Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades","volume":"104","author":"AbouAlaiwi","year":"2009","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122329_bib78","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cellbi.2008.07.021","article-title":"Centrosome overduplication and mitotic instability in PKD2 transgenic lines","volume":"32","author":"Burtey","year":"2008","journal-title":"Cell Biol. Int."},{"issue":"18","key":"10.1016\/j.biomaterials.2023.122329_bib79","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1093\/hmg\/ddn180","article-title":"Loss of polycystin-1 causes centrosome amplification and genomic instability","volume":"17","author":"Battini","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122329_bib80","doi-asserted-by":"crossref","first-page":"9975","DOI":"10.18632\/oncotarget.7198","article-title":"Identification of drugs that restore primary cilium expression in cancer cells","volume":"7","author":"Khan","year":"2016","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.biomaterials.2023.122329_bib81","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1038\/onc.2016.435","article-title":"Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition","volume":"36","author":"Dermit","year":"2017","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122329_bib82","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cellsig.2016.05.007","article-title":"Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic beta cells","volume":"28","author":"Wang","year":"2016","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122329_bib83","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2014.241","article-title":"Polycystin deficiency induces dopamine-reversible alterations in flow-mediated dilatation and vascular nitric oxide release in humans","volume":"87","author":"Lorthioir","year":"2015","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122329_bib84","first-page":"63","article-title":"Ciliotherapy: a novel intervention in polycystic kidney disease","volume":"11","author":"Kathem","year":"2014","journal-title":"J Geriatr Cardiol"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122329_bib85","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122329_bib86","doi-asserted-by":"crossref","first-page":"F958","DOI":"10.1152\/ajprenal.00489.2011","article-title":"An ACE inhibitor improves vascular outcomes in a PKD model","volume":"301","author":"Nauli","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"16","key":"10.1016\/j.biomaterials.2023.122329_bib87","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122329_bib88","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ndt\/gfx040","article-title":"Hereditary polycystic kidney disease is characterized by lymphopenia across all stages of kidney dysfunction: an observational study","volume":"33","author":"Van Laecke","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biomaterials.2023.122329_bib89","series-title":"Polycystic Kidney Disease","article-title":"Role of inflammation in polycystic kidney disease","author":"Karihaloo","year":"2015"},{"key":"10.1016\/j.biomaterials.2023.122329_bib90","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcis.2013.06.015","article-title":"Surface charge and interfacial potential of titanium dioxide nanoparticles: experimental and theoretical investigations","volume":"407","author":"Holmberg","year":"2013","journal-title":"J. Colloid Interface Sci."},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122329_bib91","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1021\/acsnano.7b01023","article-title":"Super-cationic carbon quantum dots synthesized from spermidine as an eye drop formulation for topical treatment of bacterial keratitis","volume":"11","author":"Jian","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2023.122329_bib92","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122329_bib93","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s11051-010-9911-8","article-title":"Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?","volume":"12","author":"Alkilany","year":"2010","journal-title":"J. Nanoparticle Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122329_bib94","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine (Lond)"},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122329_bib95","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.02650313","article-title":"Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study","volume":"9","author":"Braun","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122329_bib96","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122329_bib97","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1681\/ASN.2007050626","article-title":"Sirolimus reduces polycystic liver volume in ADPKD patients","volume":"19","author":"Qian","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biomaterials.2023.122329_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109468","article-title":"The PI3K\/Akt\/mTOR pathway in polycystic kidney disease: a complex interaction with polycystins and primary cilium","volume":"66","author":"Margaria","year":"2020","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122329_bib99","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/ncb2117","article-title":"Primary cilia regulate mTORC1 activity and cell size through Lkb1","volume":"12","author":"Boehlke","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122329_bib100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1681\/ASN.2010050526","article-title":"Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis","volume":"22","author":"Bell","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122329_bib101","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.kint.2020.05.049","article-title":"Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease","volume":"98","author":"Shao","year":"2020","journal-title":"Kidney Int."},{"issue":"554","key":"10.1016\/j.biomaterials.2023.122329_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba3613","article-title":"Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease","volume":"12","author":"Lu","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122329_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061994","article-title":"Oxidative stress and mitochondrial abnormalities contribute to decreased endothelial nitric oxide synthase expression and renal disease progression in early experimental polycystic kidney disease","volume":"21","author":"Kahveci","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122329_bib104","doi-asserted-by":"crossref","first-page":"F800","DOI":"10.1152\/ajprenal.00111.2015","article-title":"Acute reactive oxygen species (ROS)-dependent effects of IL-1beta, TNF-alpha, and IL-6 on the glomerular filtration barrier (GFB) in vivo","volume":"309","author":"Sverrisson","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122300337X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122300337X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:23:48Z","timestamp":1758907428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296122300337X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":104,"alternative-id":["S014296122300337X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122329","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folate conjugated nanomedicines for selective inhibition of mTOR signaling in polycystic kidneys at clinically relevant doses","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122329"}}